产品编号 :
Cas No. :
CAS No. |
1612191-86-2 |
|---|---|
英文名称 |
(3R,5S,6R,7R,8S,9S,10S,13R,14S,17R)-6-ethyl-17-((R)-4-hydroxybutan-2-yl)-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthrene-3,7-diol |
别名 |
(3R,5S,6R,7R,8S,9S,10S,13R,14S,17R)-6-ethyl-17-((R)-4-hydroxybutan-2-yl)-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthrene-3,7-diol;6α-ethyl-3α,7α-dihydroxy-24-nor-5β-cholan-23-ol;BAR 502;BAR 502, 98%, a dual FXR and GPBAR1 agonist;181945;24-Norcholane-3,7,23-triol, 6-ethyl-, (3α,5β,6α,7α)-;BAR 502;BAR-502;BAR502;GPCR19,BAR 502,G protein-coupled Bile Acid Receptor 1,BAR-502,BAR502,Autophagy,GPBAR1,NR1H4,Inhibitor,G-protein coupled receptor 19,inhibit,FXR,TGR5 |
标准英文名 |
(3R,5S,6R,7R,8S,9S,10S,13R,14S,17R)-6-ethyl-17-((R)-4-hydroxybutan-2-yl)-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthrene-3,7-diol |
分子式 |
C25H44O3 |
分子量 |
392.62 |
精确分子量 |
392.33 |
SMILES |
CC[C@H]1[C@@H](O)[C@@H]2[C@H](CC[C@]3(C)[C@@H]([C@H](C)CCO)CC[C@@H]23)[C@@]2(C)CC[C@@H](O)C[C@@H]12 |
标准SMILES |
C[C@H](CCO)[C@H]1CC[C@H]2[C@H]3[C@H](CC[C@@]21C)[C@@]1(C)CC[C@@H](O)C[C@H]1[C@@H](CC)[C@H]3O |
用途 |
BAR502 is a dual FXR and GPBAR1 agonist used for the treatment of metabolic and liver disorders. It reduces body weight, improves insulin sensitivity, and increases circulating HDL levels. BAR502 ameliorates hepatic steatosis, inflammation, and fibrosis by downregulating the expression of SrbB1c, Fas, PPARγ, CD36, and CYP7A1 mRNA in the liver. It attenuates CCl4-induced liver fibrosis and promotes browning of epididymal white adipose tissue (EPWAT). In models of non-obstructive cholestasis, BAR502 alleviates liver injury without inducing pruritus. Additionally, it enhances survival rates, reduces serum alkaline phosphatase levels, and robustly modulates hepatic expression of FXR target genes—including OSTα, BSEP, SHP, and MDR1—without causing itching. |
InChIKey |
HYCMOIGNYNCMRH-APIYUPOTSA-N |
|
|
评论 |
|---|